Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-480-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 05 April 1994 to 05 May 1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted to recent EU & OECD test guidance in compliance with GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- -
- EC Number:
- 419-480-1
- EC Name:
- -
- IUPAC Name:
- Reaction mass of tetrasodium 2-((1-(3-(6-fluoro-(4-((N-(2-(2-sulfatoethanesulfonyl)ethyl)-N-phenyl)amino)-1,3,5-triazin-2-ylamino)-2-hydroxy-5-sulfonatophenylazo)-1-phenylmethyl)azo)-4-sulfonatobenzoate cuprate (4-) and trisodium 2-((1-(3-((4-(N-(2-ethenesulfonylethyl)-N-phenyl)amino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-hydroxy-5-sulfonatophenylazo)-1-phenylmethyl)azo)-4-sulfonatobenzoate cuprate (4-)
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): Reactive Blue FC 75311
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winklemann GmbH
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 29 - 46g
- Assigned to test groups randomly: yes, under following basis: randomization plan, produced by the Institute of Biometrics, BAYER AG
- Fasting period before study: No data
- Housing: Makrolon Type 1 cages, females 3 to a cage, males 1 to a cage
- Diet (e.g. ad libitum): Altromin 1324, ad libitum
- Water (e.g. ad libitum): Tap water, ad libitum
- Acclimation period: At least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23
- Humidity (%): 40 - 70
- Air changes (per hr): Ten times
- Photoperiod (hrs dark / hrs light): 500 lux, twelve hours of electrical lighting daily (06:00 to 18:00)
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: physiol. saline
- Justification for choice of solvent/vehicle: historical usage within the laboratory. - Details on exposure:
- The test substance was dissolved in physiological saline solution and injected intraperitoneally.
The control substance, cyclophosphamide, was dissolved in deionized water and administered in the same way. The negative control received physiological saline solution by the same method. Negative and positive controls were performed in a separate control study (T 3055643), which was performed parallel to the treatment with Reactive Blue FC 75311 (T 5055645).
In all of the groups, the administered volume was 10 ml/kg body weight.
The selection of the Reactive Blue FC 75311 dose was based on a pilot test, in which groups of five animals, including both(males and females, were intraperitoneally administered 250 mg/kg, 300 mg/kg, 500 mg/kg and 1000 mg/kg Reactive Blue FC 75311. The following symptoms were recorded for up to 96 hours, starting at 250 mg/kg: apathy, roughened; fur, blue discoloration of hairless parts of skin, spasm, difficulty in breathing, eyelids stuck together and blue discoloration of urine. In addition, 1, 3 and 5 of 5 animals died in the 250, 500 and 1000 mg/kg groups.
Based on these results, 300 mg/kg Reactive Blue FC 75311 was chosen as MTD for this test. - Duration of treatment / exposure:
- 16, 24 and 48 hours
- Frequency of treatment:
- Once
- Post exposure period:
- None
Doses / concentrations
- Remarks:
- Doses / Concentrations:
300 mg/kg body weight
Basis:
other: pilot test
- No. of animals per sex per dose:
- Negative control 24 hours exposure - 10 animals, 5 males & 5 females
Male: 300 mg/kg; No. of animals: 5; Sacrifice time: 16 hours
Male: 300 mg/kg; No. of animals: 5; Sacrifice time: 24 hours
Male: 300 mg/kg; No. of animals: 5; Sacrifice time: 48 hours
Female: 300 mg/kg; No. of animals: 5; Sacrifice times: 16 hours
Female: 300 mg/kg; No. of animals: 5; Sacrifice times: 24 hours
Female: 300 mg/kg; No. of animals: 5; Sacrifice times: 48 hours
Positive control 24 hours exposure - 10 animals, 5 males & 5 females - Control animals:
- yes
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s):proven cytostatic agent and known clastogen with bifunctional alkylation action
- Route of administration: Intraperitoneally
- Doses / concentrations: 20 mg/kg body weight
Examinations
- Tissues and cell types examined:
- chromosomes of bone-marrow erythroblasts
- Details of tissue and slide preparation:
- Schmid's method was used to produce the smears. At least one intact femur was prepared from each sacrificed animal (not pretreated with a spindle inhibitor). A suitable instrument was used to sever the pelvic bones and lower leg. The femur was separated from muscular tissue. The lower-leg stump, including the knee and all attached soft parts, was separated in the distal epiphyseal cartilage by a gentle pull at the distal end.
The proximal end of the femur was opened at its extreme end with a suitable instrument, e.g. fine scissors, making visible a small opening in the bone-marrow channel. A suitable tube was filled with sufficient fetal calf serum. A small amount of serum was drawn from the tube into a suitable syringe with a thin cannula.
The cannula was pushed into the open end of the marrow cavity. The femur was then completely immersed in the calf serum and pressed against the wall of the tube, to prevent its slipping off. The contents were then flushed several times and the bone marrow was passed into the serum as a fine suspension.
Finally the flushing might be repeated from the other end, after it had been opened. The tube containing the serum and bone marrow was centrifuged in a suitable centrifuge at approximately 1000 rpm for five minutes. The supernatant was removed with a suitable pipette (e.g. Pasteur pipette), leaving only a small remainder. The sediment was mixed to produce a homogeneous suspension.
One drop of the viscous suspension was placed on a well-cleaned slide and spread with a suitable object, to .allow proper evaluation of the smear.
The labeled slides were dried overnight. If fresh smears needed to be stained, they needed to be dried with heat for a short period.
The Staining of Smears
The smears were stained automatically with an Ames Hema-TeK Slide Stainer from the Miles Company. The slides were then "destained" with methanol, rinsed with deionized water, and left to dry.
The Covering of Smears
Following this treatment, the/smears were transferred to a holder. A cuvette was filled with xylene, into which the holder was immersed for approximately ten minutes. The slides were removed singly (e.g. with tweezers) to be covered. A small amount of covering agent was taken from a bottle with a suitable object (e.g. glass rod) and applied to the coated side of the slide. A cover glass was then placed in position without trapping bubbles. The slides were not evaluated until the covering agent had dried. - Evaluation criteria:
- Coded slides were evaluated using a light microscope at a magnification of about 1000. Micronuclei appear as stained chromatin particles in the anucleated erythrocytes. These were distinguished from artifacts by varying the focus.
A test was considered positive if, at any of the intervals, there was a relevant and significant increase in the number of polychromatic erythrocytes showing micronuclei in comparison to the negative control.
A test was considered negative if there was no relevant or significant increase in the rate of micronucleated poly¬chromatic erythrocytes at any time. A test was also considered negative if there was a significant increase in that rate which, according to the laboratory's experience was within the range of negative controls. In addition, a test was considered equivocal if there was an increase of micronucleated polychromatic erythrocytes above the range of attached historical negative controls, provided the increase was not significant and the result of the negative control was not closely related to the data of the respective treatment group. In this case, a second test had to be performed at the most sensitive interval. - Statistics:
- The Reactive Blue FC 75311 group(s) with the highest mean (provided this superceded the negative control mean) and the positive control were checked by wilcoxon's non-parametric rank sum test with respect to the number of polychromatic erythrocytes having micronuclei and the number of normochromatic erythrocytes. A variation was considered statistically significant if its error probability was below 5% and the treatment groupfigure was higher than that of the negative control.
The rate of normochromatic erythrocytes containing micro-nuclei was examined if the micronuclear rate for polychromatic erythrocytes was already relevantly increased. In this case, the group with the highest mean was; compared with the negative control using the one-sided chii-test. A variation was considered statistically significant if the error probability was below 5% and the treatment group figure was higher than that of the negative control.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- After single intraperitoneal administration of 300 mg/kg Reactive Blue FC 75311, treated animals showed the following compound-related symptoms until sacrifice: apathy, roughened fur, blue discoloration of hairless parts of skin, spasm, shivering, difficulty in breathing, red tears, diarrhoea and blue discolored urine. Their feeding behavior was normal. One of 40 treated animals died during the test period, due to the acute toxicity of 300 mg/kg Reactive Blue FC 75311. No symptoms were recorded for the control groups. No animals died in these groups.
Under microscopic examination, the ratio of polychromatic to normochromatic erythrocytes was not altered by the treatment with Reactive Blue FC 75311 for the 16 and 24 hours groups. However an altered ratio was observed for the 48 hours group. These ratios were 1000: 709 (ls=192) in the negative control, 1000: 726 (ls=183) in the 16 hours group', 1000: 682 (ls=182) in the 24 hours group and 1000: lS"45 (ls=555) in the 48 hours group. A relevant variation was thus noted for the 48 hours group.
No biologically important or statistically significant variations existed between the negative control and the groups treated intra-peritoneally with 300 mg/kg Reactive Blue FC 75311, with respect to the incidence of micronucleated polychromatic erythrocytes. The incidence of these micronucleated cells> was 1.5/1000 (ls=1.4) in the negative control, and 1.9/1000 (ls=1.4), 0.9/1000 (ls=1.0) and 1.5/1000 (ls=1.3) in the Reactive Blue FC 7 5311 groups.
Similarly, there could be no biologically significant variation between the negative control and Reactive Blue FC 75311 groups in the number of micronucleated normochromatic erythrocytes, since normochromatic erythrocytes originated from polychromatic ones. As expected, relevant variations were not observed.
The positive control, cyclophosphamide, caused a clear increase in the number of polychromatic erythrocytes with micronuclei. The incidence of micronucleated cells was 16.3/1000 (ls=7.8), which represents a biologically relevant increase in comparison to the negative control.
There could not have been a biologically relevant effect on the number of micronucleated normochromatic erythrocy¬tes in the positive control since, in conjunction with the cell-cycle duration, cnormochromatic erythrocytes origi¬nated from polychromatic ones.
No further effect of cyclophosphamide was found concerning the ratio of polychromatic to normochromatic erythrocytes, since this ratio did not vary to a biologically relevant degree [1000: 729 (ls=212J, as against 1000: 709 in the negative control]. This clearly demonstrates that an alteration of the ratio of polychromatic to normochromatic erythrocytes is not necessary for the induction of micro-nuclei
Any other information on results incl. tables
Summary of Results of Micronucleus Test With Reactive Blue FC 75311 (after acute intraperitoneal treatment
|
|
|
Micronucleated cells per 1000 |
|
experimental groups |
number of evaluated polychromatic erythrocytes |
number of normochromatic erythrocytes per 1000 polychromatic erythrocytes |
normo- chromatic erythrocytes |
polychromatic erythrocytes |
negative control |
10,000 |
709 ± 192 |
1.0 ±1.l |
1.5 ± 1.4 |
test substance 16 hours |
10,000 |
726 ± 183 |
1.0 ± 1.2 |
1.9 ± 1.4 |
test substance 24 hours |
10,000 |
682 ± 182 |
1.3 ± 1.8 |
0.9 ± 1.0 |
test substance 48 hours |
10,000 |
1345* + 555 |
1.6 ± 1.1 |
1.5 ± 1.3 |
positive control CP-20 mg/kg |
10,000 |
729 ± 212 |
1.5 ± 1.4 |
16.3* ± 7.8 |
*P < 0.01 in non-parametric wilcoxon ranking test
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The micronucleus test was employed to investigate Reactive Blue FC 75311 in male and female mice for a possible clastogenic effect on the chromosomes of bone-marrow erythroblasts. The known clastogen and cytostatic agent, cyclophosphamide, served as positive control. The treated animals received a single intraperitoneal administration of either Reactive Blue FC 75311 or cyclophosphamide. The femoral marrow of groups treated with Reactive Blue FC 75311 was prepared 16, 24 and 48 hours after administration. All negative and positive control animals were sacrificed after 24 hours. The doses of Reactive Blue FC 75311 and the positive control, cyclophosphamide, were 300 and 20 mg/kg body weight, respectively.
The animals treated with Reactive Blue FC 75311 showed symptoms of toxicity after administration. One of forty animals died before the end of 'the test due to the acute intraperitoneal toxicity of 300 mg/kg Reactive Blue FC 75311.
There was an altered ratio between polychromatic and nor-mochromatic erythrocytes concerning the 48 hours sampling time. No indications of a clastogenic effect of Reactive Blue FC 75311 were found after a single intraperitoneal treatment with 300 mg/kg.
Cyclophosphamide, the positive control, had a clear clastogenic effect, as is shown by the biologically relevant increase in polychromatic erythrocytes with micronuclei. The ratio of polychromatic to normochromatic erythrocytes was not altered.
In conclusion, there was no indication of a clastogenic effect of an intraperitoneal dose of 300 mg/kg Reactive Blue FC 75311 in the micronucleus test on the mouse, i.e. in a somatic test system in vivo. - Executive summary:
The substances was assessed by intraperitoneal exposure to mice and the bone marrow harvested to determine the clastogenic potential of the substance. The study was conducted using both negative and positive controls, all of which showed expected results. The test substance gave no increase in the ration of polychromatic to normochromatic erythrocytes and is therefore considered to be non-clastogenic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.